Cassia Capital Partners, LLC Eli Lilly & CO Transaction History

Cassia Capital Partners, LLC

$150 Million
Q1 2024

A detailed history of Cassia Capital Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cassia Capital Partners, LLC holds 1,115 shares of LLY stock, worth $1 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

1,115

Previous 996 11.95%

Holding current value

$1 Million

Previous $580,000 49.48%

% of portfolio

0.58%

Previous 0.48%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$592.2 - $792.28 $70,471 - $94,281	119 Added 11.95%	1,115 $867,000
Q4 2023 Jan 29, 2024	BUY	$525.19 - $619.13 $23,633 - $27,860	45 Added 4.73%	996 $580,000
Q3 2023 Oct 16, 2023	BUY	$434.7 - $599.3 $7,389 - $10,188	17 Added 1.82%	951 $510,000
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $33,320 - $44,553	-95 Reduced 9.23%	934 $438,000
Q1 2023 Apr 21, 2023	SELL	$310.63 - $364.82 $3,416 - $4,013	-11 Reduced 1.06%	1,029 $353,000

Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $115,758 - $134,881	-360 Reduced 25.71%	1,040 $0
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $8,004 - $9,122	27 Added 1.97%	1,400 $453,000
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $9,755 - $11,454	35 Added 2.62%	1,373 $445,000
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $2,346 - $2,916	-10 Reduced 0.74%	1,338 $383,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $303,097 - $376,145	1,348 New	1,348 $372,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $245,532 - $302,162	-1,108 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $200,049 - $258,762	1,108 New	1,108 $254,000

Others Institutions Holding LLY

# of Institutions

3,722

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $853B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cassia Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cassia Capital Partners, LLC with notifications on news.

Account

Cassia Capital Partners, LLC Eli Lilly & CO Transaction History